5121 - 5130 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020Journal Name: Operative NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 5Start Page: 277End Page: 290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/ons/opab261Citation Count: 17
-
OPENTitle: Orofacial pain in 1916 patients with early or moderate Parkinson diseaseJournal Name: PAIN ReportsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 6Issue #: 1Start Page: e923End Page: e923Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1097/pr9.0000000000000923Best OA location URL: https://doi.org/10.1097/pr9.0000000000000923Citation Count: 11
-
OPENTitle: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel diseaseJournal Name: Pharmacogenetics and GenomicsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 32Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8578201Citation Count: 4
-
OPENTitle: Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 56Issue #: 12Start Page: 2672End Page: 2684Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-024-01972-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10275048Citation Count: 22
-
OPENTitle: Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traitsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 56Issue #: 12Start Page: 2685End Page: 2695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-024-01973-7Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12090064/Citation Count: 7
-
OPENTitle: Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial ImplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 3Start Page: 312End Page: 314Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13890Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10928330/pdf/MDC3-11-312.pdfCitation Count: 1
-
OPENTitle: Outcome Selection for Research Studies in Movement DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: S3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14087Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14087Citation Count: 0
-
OPENTitle: A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 12Start Page: 5690End Page: 5699Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13319Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13319Citation Count: 6
-
OPENTitle: Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 3Start Page: 294End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00785-3Best OA location URL: https://escholarship.org/uc/item/7qn6v913Citation Count: 314
-
RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 103